MedPath

MORPHINE SULFATE INJECTION EPIDURAL

MORPHINE SULFATE INJECTION EPIDURAL

Approved
DIN Number

02498286

Drug Class

Human

Market Date

Jun 2, 2021

Company
HC

Sterimax Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02498286
AIG Number0104545004
Classification & Schedule
C
Drug Class
Human
S
Schedule
Narcotic (CDSA I)
A
ATC Code
N02AA01 MORPHINE
Product Specifications
Dosage FormSolution
Route of AdministrationEpidural
AHFS Classification28:08.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

MORPHINE SULFATEActive
Strength: 1 MG / ML
Monograph: MORPHINE SULFATE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.